Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
AUTOR(ES)
Drucker, D J
RESUMO
Injury, inflammation, or resection of the small intestine results in severe compromise of intestinal function. Nevertheless, therapeutic strategies for enhancing growth and repair of the intestinal mucosal epithelium are currently not available. We demonstrate that nude mice bearing subcutaneous proglucagon-producing tumors exhibit marked proliferation of the small intestinal epithelium. The factor responsible for inducing intestinal proliferation was identified as glucagon-like peptide 2 (GLP-2), a 33-aa peptide with no previously ascribed biological function. GLP-2 stimulated crypt cell proliferation and consistently induced a marked increase in bowel weight and villus growth of the jejunum and ileum that was evident within 4 days after initiation of GLP-2 administration. These observations define a novel biological role for GLP-2 as an intestinal-derived peptide stimulator of small bowel epithelial proliferation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=38848Documentos Relacionados
- Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells
- Specific Biologic Effects of Intestinal Glucagon-Like Materials
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- Glucagon-like peptide-1 is a physiological incretin in rat.
- Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2